Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 22, 2024
A Qualitative Study to Understand the Barriers and Facilitators in Smoking Cessation Practices Among Oncology Health Care Practitioners in One Health SystemKate Frazer, Nancy Bhardwaj, Patricia Fox, et al.
Pediatric Pulmonology|May 30, 2020
Neonatal screening programme for CF: Results from the Irish Comparative Outcomes Study (ICOS)Catherine Fitzgerald, Barry Linnane, Sherly George, et al.
Breast Cancer Research and Treatment|September 27, 2007
Progesterone receptor B (PRB) promoter hypermethylation in sporadic breast cancer: progesterone receptor B hypermethylation in breast cancerOrla Mc Cormack, Wen Y Chung, Patricia Fitzpatrick, et al.
The British Journal of Ophthalmology|December 18, 2020
Irish National Diabetic RetinaScreen Programme: report on five rounds of retinopathy screening and screen-positive referrals. (INDEAR study report no. 1)Rajiv Pandey, Margaret M Morgan, Colette Murphy, et al.
Cell Cycle (Georgetown, Tex.)|August 3, 2010
MAD2 downregulation in hypoxia is independent of promoter hypermethylationMaria Prencipe, Aloysius McGoldrick, Antoinette S Perry, et al.
Journal of Medical Screening|March 21, 2024
Examining the impact of COVID-19 disruptions on population-based breast cancer screening in IrelandJessica O'Driscoll, Therese Mooney, Paul Kearney, et al.
Breast Cancer Research and Treatment|June 29, 2019
Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre studyAntonio Ponti, Guglielmo Ronco, Elsebeth Lynge, et al.
Journal of Medical Screening|July 8, 2026
A cross-sectional survey of sample takers' views on HPV self-sampling for cervical screening in IrelandPhilippa White, Salma Al-Kalbani, Sarah Fitzgibbon, et al.
The Journal of Pathology|November 10, 2011
Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancerFiona Furlong, Patricia Fitzpatrick, Sharon O'Toole, et al.
Pageof 12